Many modules are hidden in this stack. Use "module --show_hidden spider SOFTWARE" if you are not able to find the required software
# packages in environment at /cluster/home/gcardenal/miniconda3/envs/vllm:
#
# Name                    Version                   Build  Channel
_libgcc_mutex             0.1                        main  
_openmp_mutex             5.1                       1_gnu  
accelerate                1.1.1                    pypi_0    pypi
aiohappyeyeballs          2.4.0                    pypi_0    pypi
aiohttp                   3.10.6                   pypi_0    pypi
aiosignal                 1.3.1                    pypi_0    pypi
annotated-types           0.7.0                    pypi_0    pypi
anthropic                 0.40.0                   pypi_0    pypi
anyio                     4.6.0                    pypi_0    pypi
argon2-cffi               23.1.0                   pypi_0    pypi
argon2-cffi-bindings      21.2.0                   pypi_0    pypi
arrow                     1.3.0                    pypi_0    pypi
asttokens                 3.0.0                    pypi_0    pypi
async-lru                 2.0.4                    pypi_0    pypi
async-timeout             4.0.3                    pypi_0    pypi
attrs                     24.2.0                   pypi_0    pypi
babel                     2.16.0                   pypi_0    pypi
beautifulsoup4            4.12.3                   pypi_0    pypi
bleach                    6.2.0                    pypi_0    pypi
bzip2                     1.0.8                h5eee18b_6  
ca-certificates           2024.7.2             h06a4308_0  
certifi                   2024.8.30                pypi_0    pypi
cffi                      1.17.1                   pypi_0    pypi
charset-normalizer        3.3.2                    pypi_0    pypi
click                     8.1.7                    pypi_0    pypi
cloudpickle               3.0.0                    pypi_0    pypi
comm                      0.2.2                    pypi_0    pypi
datasets                  3.0.1                    pypi_0    pypi
debugpy                   1.8.9                    pypi_0    pypi
decorator                 5.1.1                    pypi_0    pypi
defusedxml                0.7.1                    pypi_0    pypi
dill                      0.3.8                    pypi_0    pypi
diskcache                 5.6.3                    pypi_0    pypi
distro                    1.9.0                    pypi_0    pypi
einops                    0.8.0                    pypi_0    pypi
emoji                     2.14.0                   pypi_0    pypi
exceptiongroup            1.2.2                    pypi_0    pypi
executing                 2.1.0                    pypi_0    pypi
fastapi                   0.115.0                  pypi_0    pypi
fastjsonschema            2.21.1                   pypi_0    pypi
filelock                  3.16.1                   pypi_0    pypi
fqdn                      1.5.1                    pypi_0    pypi
frozenlist                1.4.1                    pypi_0    pypi
fsspec                    2024.6.1                 pypi_0    pypi
gguf                      0.10.0                   pypi_0    pypi
h11                       0.14.0                   pypi_0    pypi
httpcore                  1.0.5                    pypi_0    pypi
httptools                 0.6.1                    pypi_0    pypi
httpx                     0.27.2                   pypi_0    pypi
huggingface-hub           0.25.1                   pypi_0    pypi
idna                      3.10                     pypi_0    pypi
importlib-metadata        8.5.0                    pypi_0    pypi
interegular               0.3.3                    pypi_0    pypi
ipykernel                 6.29.5                   pypi_0    pypi
ipython                   8.30.0                   pypi_0    pypi
ipywidgets                8.1.5                    pypi_0    pypi
isoduration               20.11.0                  pypi_0    pypi
jedi                      0.19.2                   pypi_0    pypi
jinja2                    3.1.4                    pypi_0    pypi
jiter                     0.5.0                    pypi_0    pypi
json5                     0.10.0                   pypi_0    pypi
jsonpointer               3.0.0                    pypi_0    pypi
jsonschema                4.23.0                   pypi_0    pypi
jsonschema-specifications 2023.12.1                pypi_0    pypi
jupyter                   1.1.1                    pypi_0    pypi
jupyter-client            8.6.3                    pypi_0    pypi
jupyter-console           6.6.3                    pypi_0    pypi
jupyter-core              5.7.2                    pypi_0    pypi
jupyter-events            0.10.0                   pypi_0    pypi
jupyter-lsp               2.2.5                    pypi_0    pypi
jupyter-server            2.14.2                   pypi_0    pypi
jupyter-server-terminals  0.5.3                    pypi_0    pypi
jupyterlab                4.3.2                    pypi_0    pypi
jupyterlab-pygments       0.3.0                    pypi_0    pypi
jupyterlab-server         2.27.3                   pypi_0    pypi
jupyterlab-widgets        3.0.13                   pypi_0    pypi
lark                      1.2.2                    pypi_0    pypi
ld_impl_linux-64          2.40                 h12ee557_0  
libffi                    3.4.4                h6a678d5_1  
libgcc-ng                 11.2.0               h1234567_1  
libgomp                   11.2.0               h1234567_1  
libstdcxx-ng              11.2.0               h1234567_1  
libuuid                   1.41.5               h5eee18b_0  
llvmlite                  0.43.0                   pypi_0    pypi
lm-format-enforcer        0.10.6                   pypi_0    pypi
markupsafe                2.1.5                    pypi_0    pypi
matplotlib-inline         0.1.7                    pypi_0    pypi
mistral-common            1.4.3                    pypi_0    pypi
mistune                   3.0.2                    pypi_0    pypi
mpmath                    1.3.0                    pypi_0    pypi
msgpack                   1.1.0                    pypi_0    pypi
msgspec                   0.18.6                   pypi_0    pypi
multidict                 6.1.0                    pypi_0    pypi
multiprocess              0.70.16                  pypi_0    pypi
nbclient                  0.10.1                   pypi_0    pypi
nbconvert                 7.16.4                   pypi_0    pypi
nbformat                  5.10.4                   pypi_0    pypi
ncurses                   6.4                  h6a678d5_0  
nest-asyncio              1.6.0                    pypi_0    pypi
networkx                  3.3                      pypi_0    pypi
notebook                  7.3.1                    pypi_0    pypi
notebook-shim             0.2.4                    pypi_0    pypi
numba                     0.60.0                   pypi_0    pypi
numpy                     1.26.4                   pypi_0    pypi
nvidia-cublas-cu12        12.1.3.1                 pypi_0    pypi
nvidia-cuda-cupti-cu12    12.1.105                 pypi_0    pypi
nvidia-cuda-nvrtc-cu12    12.1.105                 pypi_0    pypi
nvidia-cuda-runtime-cu12  12.1.105                 pypi_0    pypi
nvidia-cudnn-cu12         9.1.0.70                 pypi_0    pypi
nvidia-cufft-cu12         11.0.2.54                pypi_0    pypi
nvidia-curand-cu12        10.3.2.106               pypi_0    pypi
nvidia-cusolver-cu12      11.4.5.107               pypi_0    pypi
nvidia-cusparse-cu12      12.1.0.106               pypi_0    pypi
nvidia-ml-py              12.560.30                pypi_0    pypi
nvidia-nccl-cu12          2.20.5                   pypi_0    pypi
nvidia-nvjitlink-cu12     12.6.68                  pypi_0    pypi
nvidia-nvtx-cu12          12.1.105                 pypi_0    pypi
openai                    1.48.0                   pypi_0    pypi
openssl                   3.0.15               h5eee18b_0  
outlines                  0.0.46                   pypi_0    pypi
overrides                 7.7.0                    pypi_0    pypi
packaging                 24.1                     pypi_0    pypi
pandas                    2.2.3                    pypi_0    pypi
pandocfilters             1.5.1                    pypi_0    pypi
parso                     0.8.4                    pypi_0    pypi
partial-json-parser       0.2.1.1.post4            pypi_0    pypi
pexpect                   4.9.0                    pypi_0    pypi
pillow                    10.4.0                   pypi_0    pypi
pip                       24.2            py310h06a4308_0  
platformdirs              4.3.6                    pypi_0    pypi
plotly                    5.24.1                   pypi_0    pypi
prometheus-client         0.21.0                   pypi_0    pypi
prometheus-fastapi-instrumentator 7.0.0                    pypi_0    pypi
prompt-toolkit            3.0.48                   pypi_0    pypi
protobuf                  5.28.2                   pypi_0    pypi
psutil                    6.0.0                    pypi_0    pypi
ptyprocess                0.7.0                    pypi_0    pypi
pure-eval                 0.2.3                    pypi_0    pypi
py-cpuinfo                9.0.0                    pypi_0    pypi
pyairports                2.1.1                    pypi_0    pypi
pyarrow                   17.0.0                   pypi_0    pypi
pycountry                 24.6.1                   pypi_0    pypi
pycparser                 2.22                     pypi_0    pypi
pydantic                  2.9.2                    pypi_0    pypi
pydantic-core             2.23.4                   pypi_0    pypi
pygments                  2.18.0                   pypi_0    pypi
python                    3.10.14              h955ad1f_1  
python-dateutil           2.9.0.post0              pypi_0    pypi
python-dotenv             1.0.1                    pypi_0    pypi
python-json-logger        2.0.7                    pypi_0    pypi
pytz                      2024.2                   pypi_0    pypi
pyyaml                    6.0.2                    pypi_0    pypi
pyzmq                     26.2.0                   pypi_0    pypi
ray                       2.37.0                   pypi_0    pypi
readline                  8.2                  h5eee18b_0  
referencing               0.35.1                   pypi_0    pypi
regex                     2024.9.11                pypi_0    pypi
requests                  2.32.3                   pypi_0    pypi
rfc3339-validator         0.1.4                    pypi_0    pypi
rfc3986-validator         0.1.1                    pypi_0    pypi
rpds-py                   0.20.0                   pypi_0    pypi
safetensors               0.4.5                    pypi_0    pypi
send2trash                1.8.3                    pypi_0    pypi
sentencepiece             0.2.0                    pypi_0    pypi
setuptools                75.1.0          py310h06a4308_0  
six                       1.16.0                   pypi_0    pypi
sniffio                   1.3.1                    pypi_0    pypi
soupsieve                 2.6                      pypi_0    pypi
sqlite                    3.45.3               h5eee18b_0  
stack-data                0.6.3                    pypi_0    pypi
stanza                    1.9.2                    pypi_0    pypi
starlette                 0.38.6                   pypi_0    pypi
sympy                     1.13.3                   pypi_0    pypi
tenacity                  9.0.0                    pypi_0    pypi
terminado                 0.18.1                   pypi_0    pypi
tiktoken                  0.7.0                    pypi_0    pypi
timm                      1.0.12                   pypi_0    pypi
tinycss2                  1.4.0                    pypi_0    pypi
tk                        8.6.14               h39e8969_0  
tokenizers                0.20.0                   pypi_0    pypi
tomli                     2.2.1                    pypi_0    pypi
torch                     2.4.0                    pypi_0    pypi
torchvision               0.19.0                   pypi_0    pypi
tornado                   6.4.2                    pypi_0    pypi
tqdm                      4.66.5                   pypi_0    pypi
traitlets                 5.14.3                   pypi_0    pypi
transformers              4.45.0                   pypi_0    pypi
triton                    3.0.0                    pypi_0    pypi
types-python-dateutil     2.9.0.20241003           pypi_0    pypi
typing-extensions         4.12.2                   pypi_0    pypi
tzdata                    2024.2                   pypi_0    pypi
uri-template              1.3.0                    pypi_0    pypi
urllib3                   2.2.3                    pypi_0    pypi
uvicorn                   0.30.6                   pypi_0    pypi
uvloop                    0.20.0                   pypi_0    pypi
vllm                      0.6.2                    pypi_0    pypi
watchfiles                0.24.0                   pypi_0    pypi
wcwidth                   0.2.13                   pypi_0    pypi
webcolors                 24.11.1                  pypi_0    pypi
webencodings              0.5.1                    pypi_0    pypi
websocket-client          1.8.0                    pypi_0    pypi
websockets                13.1                     pypi_0    pypi
wheel                     0.44.0          py310h06a4308_0  
widgetsnbextension        4.0.13                   pypi_0    pypi
xformers                  0.0.27.post2             pypi_0    pypi
xxhash                    3.5.0                    pypi_0    pypi
xz                        5.4.6                h5eee18b_1  
yarl                      1.12.1                   pypi_0    pypi
zipp                      3.20.2                   pypi_0    pypi
zlib                      1.2.13               h5eee18b_1  
Package                           Version
--------------------------------- --------------
accelerate                        1.1.1
aiohappyeyeballs                  2.4.0
aiohttp                           3.10.6
aiosignal                         1.3.1
annotated-types                   0.7.0
anthropic                         0.40.0
anyio                             4.6.0
argon2-cffi                       23.1.0
argon2-cffi-bindings              21.2.0
arrow                             1.3.0
asttokens                         3.0.0
async-lru                         2.0.4
async-timeout                     4.0.3
attrs                             24.2.0
babel                             2.16.0
beautifulsoup4                    4.12.3
bleach                            6.2.0
certifi                           2024.8.30
cffi                              1.17.1
charset-normalizer                3.3.2
click                             8.1.7
cloudpickle                       3.0.0
comm                              0.2.2
datasets                          3.0.1
debugpy                           1.8.9
decorator                         5.1.1
defusedxml                        0.7.1
dill                              0.3.8
diskcache                         5.6.3
distro                            1.9.0
einops                            0.8.0
emoji                             2.14.0
exceptiongroup                    1.2.2
executing                         2.1.0
fastapi                           0.115.0
fastjsonschema                    2.21.1
filelock                          3.16.1
fqdn                              1.5.1
frozenlist                        1.4.1
fsspec                            2024.6.1
gguf                              0.10.0
h11                               0.14.0
httpcore                          1.0.5
httptools                         0.6.1
httpx                             0.27.2
huggingface-hub                   0.25.1
idna                              3.10
importlib_metadata                8.5.0
interegular                       0.3.3
ipykernel                         6.29.5
ipython                           8.30.0
ipywidgets                        8.1.5
isoduration                       20.11.0
jedi                              0.19.2
Jinja2                            3.1.4
jiter                             0.5.0
json5                             0.10.0
jsonpointer                       3.0.0
jsonschema                        4.23.0
jsonschema-specifications         2023.12.1
jupyter                           1.1.1
jupyter_client                    8.6.3
jupyter-console                   6.6.3
jupyter_core                      5.7.2
jupyter-events                    0.10.0
jupyter-lsp                       2.2.5
jupyter_server                    2.14.2
jupyter_server_terminals          0.5.3
jupyterlab                        4.3.2
jupyterlab_pygments               0.3.0
jupyterlab_server                 2.27.3
jupyterlab_widgets                3.0.13
lark                              1.2.2
llvmlite                          0.43.0
lm-format-enforcer                0.10.6
MarkupSafe                        2.1.5
matplotlib-inline                 0.1.7
mistral_common                    1.4.3
mistune                           3.0.2
mpmath                            1.3.0
msgpack                           1.1.0
msgspec                           0.18.6
multidict                         6.1.0
multiprocess                      0.70.16
nbclient                          0.10.1
nbconvert                         7.16.4
nbformat                          5.10.4
nest-asyncio                      1.6.0
networkx                          3.3
notebook                          7.3.1
notebook_shim                     0.2.4
numba                             0.60.0
numpy                             1.26.4
nvidia-cublas-cu12                12.1.3.1
nvidia-cuda-cupti-cu12            12.1.105
nvidia-cuda-nvrtc-cu12            12.1.105
nvidia-cuda-runtime-cu12          12.1.105
nvidia-cudnn-cu12                 9.1.0.70
nvidia-cufft-cu12                 11.0.2.54
nvidia-curand-cu12                10.3.2.106
nvidia-cusolver-cu12              11.4.5.107
nvidia-cusparse-cu12              12.1.0.106
nvidia-ml-py                      12.560.30
nvidia-nccl-cu12                  2.20.5
nvidia-nvjitlink-cu12             12.6.68
nvidia-nvtx-cu12                  12.1.105
openai                            1.48.0
outlines                          0.0.46
overrides                         7.7.0
packaging                         24.1
pandas                            2.2.3
pandocfilters                     1.5.1
parso                             0.8.4
partial-json-parser               0.2.1.1.post4
pexpect                           4.9.0
pillow                            10.4.0
pip                               24.2
platformdirs                      4.3.6
plotly                            5.24.1
prometheus_client                 0.21.0
prometheus-fastapi-instrumentator 7.0.0
prompt_toolkit                    3.0.48
protobuf                          5.28.2
psutil                            6.0.0
ptyprocess                        0.7.0
pure_eval                         0.2.3
py-cpuinfo                        9.0.0
pyairports                        2.1.1
pyarrow                           17.0.0
pycountry                         24.6.1
pycparser                         2.22
pydantic                          2.9.2
pydantic_core                     2.23.4
Pygments                          2.18.0
python-dateutil                   2.9.0.post0
python-dotenv                     1.0.1
python-json-logger                2.0.7
pytz                              2024.2
PyYAML                            6.0.2
pyzmq                             26.2.0
ray                               2.37.0
referencing                       0.35.1
regex                             2024.9.11
requests                          2.32.3
rfc3339-validator                 0.1.4
rfc3986-validator                 0.1.1
rpds-py                           0.20.0
safetensors                       0.4.5
Send2Trash                        1.8.3
sentencepiece                     0.2.0
setuptools                        75.1.0
six                               1.16.0
sniffio                           1.3.1
soupsieve                         2.6
stack-data                        0.6.3
stanza                            1.9.2
starlette                         0.38.6
sympy                             1.13.3
tenacity                          9.0.0
terminado                         0.18.1
tiktoken                          0.7.0
timm                              1.0.12
tinycss2                          1.4.0
tokenizers                        0.20.0
tomli                             2.2.1
torch                             2.4.0
torchvision                       0.19.0
tornado                           6.4.2
tqdm                              4.66.5
traitlets                         5.14.3
transformers                      4.45.0
triton                            3.0.0
types-python-dateutil             2.9.0.20241003
typing_extensions                 4.12.2
tzdata                            2024.2
uri-template                      1.3.0
urllib3                           2.2.3
uvicorn                           0.30.6
uvloop                            0.20.0
vllm                              0.6.2
watchfiles                        0.24.0
wcwidth                           0.2.13
webcolors                         24.11.1
webencodings                      0.5.1
websocket-client                  1.8.0
websockets                        13.1
wheel                             0.44.0
widgetsnbextension                4.0.13
xformers                          0.0.27.post2
xxhash                            3.5.0
yarl                              1.12.1
zipp                              3.20.2

Currently Loaded Modules:
  1) eth_proxy      4) stack/2024-06   7) python/3.11.6  10) openblas/0.3.24
  2) julia/1.10.3   5) r/4.3.2         8) cuda/12.1.1    11) python_cuda/3.11.6
  3) gcc/12.2.0     6) hdf5/1.14.3     9) nccl/2.18.3-1

 

Testing Slurm Variables...
SLURM_JOB_USER=gcardenal
SLURM_TASKS_PER_NODE=1
SLURM_JOB_UID=608619
SLURM_TASK_PID=3607956
SLURM_JOB_GPUS=1,3,4
SLURM_LOCALID=0
SLURM_SUBMIT_DIR=/cluster/home/gcardenal/HIV/deploy_medical_LLM_evaluation/deploy_medical_llm_evaluation
SLURMD_NODENAME=eu-a65-06
SLURM_JOB_START_TIME=1737204968
SLURM_CLUSTER_NAME=euler-24-production
SLURM_JOB_END_TIME=1737219368
SLURM_CPUS_ON_NODE=8
SLURM_JOB_CPUS_PER_NODE=8
SLURM_GPUS_ON_NODE=3
SLURM_GTIDS=0
SLURM_JOB_PARTITION=gpupr.4h
SLURM_TRES_PER_TASK=cpu=8
SLURM_JOB_NUM_NODES=1
SLURM_JOBID=21166741
SLURM_GPUS=nvidia_a100_80gb_pcie:3
SLURM_JOB_QOS=es_ilic/gpupr/4
SLURM_PROCID=0
SLURM_CPUS_PER_TASK=8
SLURM_NTASKS=1
SLURM_TOPOLOGY_ADDR=.euler_a100_80_lca_ib.eu-a65-06
SLURM_TOPOLOGY_ADDR_PATTERN=switch.switch.node
SLURM_MEM_PER_CPU=10240
SLURM_SCRIPT_CONTEXT=prolog_task
SLURM_NODELIST=eu-a65-06
SLURM_JOB_ACCOUNT=gpupr/es_ilic
SLURM_PRIO_PROCESS=0
SLURM_NPROCS=1
SLURM_NNODES=1
SLURM_SUBMIT_HOST=eu-g5-030-1
SLURM_JOB_ID=21166741
SLURM_NODEID=0
SLURM_CONF=/cluster/slurm/adm/etc/slurm.conf
SLURM_JOB_NAME=llama_no_api
SLURM_JOB_GID=492010
SLURM_JOB_NODELIST=eu-a65-06
Sat Jan 18 13:56:21 2025       
+-----------------------------------------------------------------------------------------+
| NVIDIA-SMI 550.127.08             Driver Version: 550.127.08     CUDA Version: 12.4     |
|-----------------------------------------+------------------------+----------------------+
| GPU  Name                 Persistence-M | Bus-Id          Disp.A | Volatile Uncorr. ECC |
| Fan  Temp   Perf          Pwr:Usage/Cap |           Memory-Usage | GPU-Util  Compute M. |
|                                         |                        |               MIG M. |
|=========================================+========================+======================|
|   0  NVIDIA A100 80GB PCIe          On  |   00000000:08:00.0 Off |                    0 |
| N/A   32C    P0             44W /  300W |       1MiB /  81920MiB |      0%      Default |
|                                         |                        |             Disabled |
+-----------------------------------------+------------------------+----------------------+
|   1  NVIDIA A100 80GB PCIe          On  |   00000000:48:00.0 Off |                    0 |
| N/A   31C    P0             41W /  300W |       1MiB /  81920MiB |      0%      Default |
|                                         |                        |             Disabled |
+-----------------------------------------+------------------------+----------------------+
|   2  NVIDIA A100 80GB PCIe          On  |   00000000:4C:00.0 Off |                    0 |
| N/A   31C    P0             43W /  300W |       1MiB /  81920MiB |      0%      Default |
|                                         |                        |             Disabled |
+-----------------------------------------+------------------------+----------------------+
                                                                                         
+-----------------------------------------------------------------------------------------+
| Processes:                                                                              |
|  GPU   GI   CI        PID   Type   Process name                              GPU Memory |
|        ID   ID                                                               Usage      |
|=========================================================================================|
|  No running processes found                                                             |
+-----------------------------------------------------------------------------------------+
Node IP: 10.205.9.15
JobId=21166741 JobName=llama_no_api
   UserId=gcardenal(608619) GroupId=gcardenal-group(492010) MCS_label=N/A
   Priority=5806 Nice=0 Account=gpupr/es_ilic QOS=es_ilic/gpupr/4
   JobState=RUNNING Reason=None Dependency=(null)
   Requeue=0 Restarts=0 BatchFlag=1 Reboot=0 ExitCode=0:0
   RunTime=00:00:14 TimeLimit=04:00:00 TimeMin=N/A
   SubmitTime=2025-01-18T13:56:07 EligibleTime=2025-01-18T13:56:07
   AccrueTime=2025-01-18T13:56:07
   StartTime=2025-01-18T13:56:08 EndTime=2025-01-18T17:56:08 Deadline=N/A
   SuspendTime=None SecsPreSuspend=0 LastSchedEval=2025-01-18T13:56:08 Scheduler=Main
   Partition=gpupr.4h AllocNode:Sid=eu-g5-030-1:391019
   ReqNodeList=(null) ExcNodeList=(null)
   NodeList=eu-a65-06
   BatchHost=eu-a65-06
   NumNodes=1 NumCPUs=8 NumTasks=1 CPUs/Task=8 ReqB:S:C:T=0:0:*:*
   ReqTRES=cpu=8,mem=80G,node=1,billing=347340,gres/gpu=3,gres/gpu:nvidia_a100_80gb_pcie=3,gres/gpumem=85899345920
   AllocTRES=cpu=8,mem=80G,node=1,billing=347340,gres/gpu=3,gres/gpu:nvidia_a100_80gb_pcie=3,gres/gpumem=0
   Socks/Node=* NtasksPerN:B:S:C=0:0:*:1 CoreSpec=*
   MinCPUsNode=8 MinMemoryCPU=10G MinTmpDiskNode=0
   Features=(null) DelayBoot=00:00:00
   OverSubscribe=OK Contiguous=0 Licenses=(null) Network=(null)
   Command=/cluster/home/gcardenal/HIV/deploy_medical_LLM_evaluation/deploy_medical_llm_evaluation/generate_answers.sh
   WorkDir=/cluster/home/gcardenal/HIV/deploy_medical_LLM_evaluation/deploy_medical_llm_evaluation
   StdErr=/cluster/home/gcardenal/HIV/deploy_medical_LLM_evaluation/deploy_medical_llm_evaluation/llama_no_api21166741.out
   StdIn=/dev/null
   StdOut=/cluster/home/gcardenal/HIV/deploy_medical_LLM_evaluation/deploy_medical_llm_evaluation/llama_no_api21166741.out
   TresPerJob=gres/gpu:nvidia_a100_80gb_pcie:3
   TresPerNode=gres/gpumem:80G
   TresPerTask=cpu=8
   

Running in standalone mode...
I0118 13:56:24.780000 23125024229184 torch/distributed/run.py:859] 
I0118 13:56:24.780000 23125024229184 torch/distributed/run.py:859] **************************************
I0118 13:56:24.780000 23125024229184 torch/distributed/run.py:859] Rendezvous info:
I0118 13:56:24.780000 23125024229184 torch/distributed/run.py:859] --rdzv-backend=c10d --rdzv-endpoint=localhost:0 --rdzv-id=e9200775-b236-4e70-83bd-a3fa3da6a4b3
I0118 13:56:24.780000 23125024229184 torch/distributed/run.py:859] **************************************
I0118 13:56:24.780000 23125024229184 torch/distributed/run.py:859] 
I0118 13:56:24.781000 23125024229184 torch/distributed/launcher/api.py:188] Starting elastic_operator with launch configs:
I0118 13:56:24.781000 23125024229184 torch/distributed/launcher/api.py:188]   entrypoint       : get_model_answers_and_prompt_generation.py
I0118 13:56:24.781000 23125024229184 torch/distributed/launcher/api.py:188]   min_nodes        : 1
I0118 13:56:24.781000 23125024229184 torch/distributed/launcher/api.py:188]   max_nodes        : 1
I0118 13:56:24.781000 23125024229184 torch/distributed/launcher/api.py:188]   nproc_per_node   : 1
I0118 13:56:24.781000 23125024229184 torch/distributed/launcher/api.py:188]   run_id           : e9200775-b236-4e70-83bd-a3fa3da6a4b3
I0118 13:56:24.781000 23125024229184 torch/distributed/launcher/api.py:188]   rdzv_backend     : c10d
I0118 13:56:24.781000 23125024229184 torch/distributed/launcher/api.py:188]   rdzv_endpoint    : localhost:0
I0118 13:56:24.781000 23125024229184 torch/distributed/launcher/api.py:188]   rdzv_configs     : {'timeout': 900}
I0118 13:56:24.781000 23125024229184 torch/distributed/launcher/api.py:188]   max_restarts     : 0
I0118 13:56:24.781000 23125024229184 torch/distributed/launcher/api.py:188]   monitor_interval : 5
I0118 13:56:24.781000 23125024229184 torch/distributed/launcher/api.py:188]   log_dir          : /scratch/tmp.21166741.gcardenal/torchelastic_jqbao2p6
I0118 13:56:24.781000 23125024229184 torch/distributed/launcher/api.py:188]   metrics_cfg      : {}
I0118 13:56:24.781000 23125024229184 torch/distributed/launcher/api.py:188] 
I0118 13:56:24.798000 23125024229184 torch/distributed/elastic/agent/server/api.py:866] [default] starting workers for entrypoint: python3
I0118 13:56:24.798000 23125024229184 torch/distributed/elastic/agent/server/api.py:699] [default] Rendezvous'ing worker group
I0118 13:56:25.104000 23125024229184 torch/distributed/elastic/agent/server/api.py:568] [default] Rendezvous complete for workers. Result:
I0118 13:56:25.104000 23125024229184 torch/distributed/elastic/agent/server/api.py:568]   restart_count=0
I0118 13:56:25.104000 23125024229184 torch/distributed/elastic/agent/server/api.py:568]   master_addr=eu-a65-06.euler.ethz.ch
I0118 13:56:25.104000 23125024229184 torch/distributed/elastic/agent/server/api.py:568]   master_port=46795
I0118 13:56:25.104000 23125024229184 torch/distributed/elastic/agent/server/api.py:568]   group_rank=0
I0118 13:56:25.104000 23125024229184 torch/distributed/elastic/agent/server/api.py:568]   group_world_size=1
I0118 13:56:25.104000 23125024229184 torch/distributed/elastic/agent/server/api.py:568]   local_ranks=[0]
I0118 13:56:25.104000 23125024229184 torch/distributed/elastic/agent/server/api.py:568]   role_ranks=[0]
I0118 13:56:25.104000 23125024229184 torch/distributed/elastic/agent/server/api.py:568]   global_ranks=[0]
I0118 13:56:25.104000 23125024229184 torch/distributed/elastic/agent/server/api.py:568]   role_world_sizes=[1]
I0118 13:56:25.104000 23125024229184 torch/distributed/elastic/agent/server/api.py:568]   global_world_sizes=[1]
I0118 13:56:25.104000 23125024229184 torch/distributed/elastic/agent/server/api.py:568] 
I0118 13:56:25.104000 23125024229184 torch/distributed/elastic/agent/server/api.py:707] [default] Starting worker group
I0118 13:56:25.105000 23125024229184 torch/distributed/elastic/agent/server/local_elastic_agent.py:168] Environment variable 'TORCHELASTIC_ENABLE_FILE_TIMER' not found. Do not start FileTimerServer.
I0118 13:56:25.105000 23125024229184 torch/distributed/elastic/multiprocessing/api.py:263] log directory set to: /scratch/tmp.21166741.gcardenal/torchelastic_jqbao2p6/e9200775-b236-4e70-83bd-a3fa3da6a4b3_vi1rfoy8
I0118 13:56:25.105000 23125024229184 torch/distributed/elastic/multiprocessing/api.py:358] Setting worker0 reply file to: /scratch/tmp.21166741.gcardenal/torchelastic_jqbao2p6/e9200775-b236-4e70-83bd-a3fa3da6a4b3_vi1rfoy8/attempt_0/0/error.json
2025-01-18 13:56:30.401108: E external/local_xla/xla/stream_executor/cuda/cuda_dnn.cc:9261] Unable to register cuDNN factory: Attempting to register factory for plugin cuDNN when one has already been registered
2025-01-18 13:56:30.401150: E external/local_xla/xla/stream_executor/cuda/cuda_fft.cc:607] Unable to register cuFFT factory: Attempting to register factory for plugin cuFFT when one has already been registered
2025-01-18 13:56:30.402408: E external/local_xla/xla/stream_executor/cuda/cuda_blas.cc:1515] Unable to register cuBLAS factory: Attempting to register factory for plugin cuBLAS when one has already been registered
2025-01-18 13:56:30.408012: I tensorflow/core/platform/cpu_feature_guard.cc:182] This TensorFlow binary is optimized to use available CPU instructions in performance-critical operations.
To enable the following instructions: AVX2 FMA, in other operations, rebuild TensorFlow with the appropriate compiler flags.
2025-01-18 13:56:31.731637: W tensorflow/compiler/tf2tensorrt/utils/py_utils.cc:38] TF-TRT Warning: Could not find TensorRT
API call for Meditron failed with error: Connection error.
Falling back to local Meditron inference - Loading model...
Loading checkpoint shards:   0%|                                                     | 0/30 [00:00<?, ?it/s]Loading checkpoint shards:   3%|█▌                                           | 1/30 [00:50<24:26, 50.57s/it]Loading checkpoint shards:   7%|███                                          | 2/30 [02:01<29:16, 62.73s/it]Loading checkpoint shards:  10%|████▌                                        | 3/30 [02:05<16:10, 35.95s/it]Loading checkpoint shards:  13%|██████                                       | 4/30 [02:15<11:08, 25.71s/it]Loading checkpoint shards:  17%|███████▌                                     | 5/30 [03:14<15:38, 37.52s/it]Loading checkpoint shards:  20%|█████████                                    | 6/30 [04:23<19:15, 48.14s/it]Loading checkpoint shards:  23%|██████████▌                                  | 7/30 [05:32<21:07, 55.12s/it]Loading checkpoint shards:  27%|████████████                                 | 8/30 [06:42<21:59, 59.97s/it]Loading checkpoint shards:  30%|█████████████▌                               | 9/30 [07:57<22:32, 64.39s/it]Loading checkpoint shards:  33%|██████████████▋                             | 10/30 [08:00<15:11, 45.58s/it]Loading checkpoint shards:  37%|████████████████▏                           | 11/30 [09:12<16:59, 53.68s/it]Loading checkpoint shards:  40%|█████████████████▌                          | 12/30 [10:37<18:55, 63.06s/it]Loading checkpoint shards:  43%|███████████████████                         | 13/30 [12:02<19:44, 69.70s/it]Loading checkpoint shards:  47%|████████████████████▌                       | 14/30 [13:22<19:28, 73.01s/it]Loading checkpoint shards:  50%|██████████████████████                      | 15/30 [13:26<13:03, 52.24s/it]Loading checkpoint shards:  53%|███████████████████████▍                    | 16/30 [14:26<12:42, 54.48s/it]Loading checkpoint shards:  57%|████████████████████████▉                   | 17/30 [14:31<08:33, 39.48s/it]Loading checkpoint shards:  60%|██████████████████████████▍                 | 18/30 [15:30<09:04, 45.37s/it]Loading checkpoint shards:  63%|███████████████████████████▊                | 19/30 [15:35<06:07, 33.40s/it]Loading checkpoint shards:  67%|█████████████████████████████▎              | 20/30 [15:39<04:04, 24.47s/it]Loading checkpoint shards:  70%|██████████████████████████████▊             | 21/30 [16:46<05:36, 37.40s/it]Loading checkpoint shards:  73%|████████████████████████████████▎           | 22/30 [17:38<05:32, 41.61s/it]Loading checkpoint shards:  77%|█████████████████████████████████▋          | 23/30 [18:59<06:14, 53.55s/it]Loading checkpoint shards:  80%|███████████████████████████████████▏        | 24/30 [19:04<03:53, 38.95s/it]Loading checkpoint shards:  83%|████████████████████████████████████▋       | 25/30 [20:04<03:45, 45.11s/it]Loading checkpoint shards:  87%|██████████████████████████████████████▏     | 26/30 [20:07<02:10, 32.70s/it]Loading checkpoint shards:  90%|███████████████████████████████████████▌    | 27/30 [20:31<01:30, 30.05s/it]Loading checkpoint shards:  93%|█████████████████████████████████████████   | 28/30 [20:35<00:44, 22.17s/it]Loading checkpoint shards:  97%|██████████████████████████████████████████▌ | 29/30 [21:32<00:32, 32.57s/it]Loading checkpoint shards: 100%|████████████████████████████████████████████| 30/30 [21:49<00:00, 27.92s/it]Loading checkpoint shards: 100%|████████████████████████████████████████████| 30/30 [21:49<00:00, 43.65s/it]
Starting inference for question locally (Meditron): How is HIV diagnosed?
<|begin_of_text|><|start_header_id|>system<|end_header_id|>

<|eot_id|><|start_header_id|>user<|end_header_id|>

How is HIV diagnosed?<|eot_id|><|start_header_id|>assistant<|end_header_id|>

## HIV Diagnosis

HIV diagnosis is a crucial step in managing the disease. The process involves several tests, each serving a specific purpose.

### Tests Used for HIV Diagnosis

1. **Rapid Tests**: These tests detect the presence of HIV antibodies in the blood. They are often used for initial screening and can provide results within 20 minutes.
2. **ELISA (Enzyme-Linked Immunosorbent Assay)**: This test is used to confirm the presence of HIV antibodies in the blood. It is more sensitive than rapid tests but takes longer to produce results.
3. **Western Blot**: This test is used to confirm the presence of HIV antibodies in the blood. It is more specific than ELISA and is often used to confirm a positive ELISA result.
4. **PCR (Polymerase Chain Reaction)**: This test detects the genetic material of the HIV virus in the blood. It is used to confirm the presence of HIV in individuals who have a positive antibody test but are still in the early stages of infection.

### Confirmation of HIV Infection

A positive result on any of these tests indicates the presence of HIV antibodies or genetic material in the blood. However, a positive result does not necessarily mean that the individual is infected with HIV. To confirm HIV infection, a second test is required to detect the presence of HIV genetic material in the blood.

### HIV Diagnosis Process

1. Initial screening with a rapid test or ELISA
2. Confirmation with a Western Blot or PCR test
3. Detection of HIV genetic material in the blood using PCR
4. Confirmation of HIV infection with a second test

### Importance of HIV Diagnosis

Early diagnosis of HIV is crucial in managing the disease. It allows individuals to receive antiretroviral therapy (ART), which can slow the progression of the disease and improve quality of life. Regular testing and monitoring are essential for individuals at high risk of HIV infection.
API call for Meditron failed with error: Connection error.
Starting inference for question locally (Meditron): What are the different stages of HIV?
<|begin_of_text|><|start_header_id|>system<|end_header_id|>

<|eot_id|><|start_header_id|>user<|end_header_id|>

What are the different stages of HIV?<|eot_id|><|start_header_id|>assistant<|end_header_id|>

## Stages of HIV Infection

HIV infection progresses through several stages, each with distinct characteristics and clinical manifestations. Understanding these stages is crucial for effective management and treatment of the disease.

### Stages of HIV Infection:

#### 1. **Acute HIV Infection**
The initial stage of HIV infection, characterized by the presence of the virus in the body and the onset of symptoms such as fever, rash, and swollen lymph nodes.

#### 2. **Asymptomatic HIV Infection**
A stage where the individual is infected with HIV but does not exhibit any noticeable symptoms. This stage can last for several years.

#### 3. **Symptomatic HIV Infection**
A stage where the individual starts to experience symptoms related to HIV infection, such as weight loss, fatigue, and recurring infections.

#### 4. **AIDS (Acquired Immunodeficiency Syndrome)**
The final stage of HIV infection, characterized by a severely weakened immune system, making the individual susceptible to opportunistic infections and certain types of cancer.

### Summary:
The progression of HIV infection through these stages highlights the importance of early detection, treatment, and management to prevent the development of AIDS and improve the quality of life for individuals living with HIV.
API call for Meditron failed with error: Connection error.
Starting inference for question locally (Meditron): How is HIV transmitted?
<|begin_of_text|><|start_header_id|>system<|end_header_id|>

<|eot_id|><|start_header_id|>user<|end_header_id|>

How is HIV transmitted?<|eot_id|><|start_header_id|>assistant<|end_header_id|>

## HIV Transmission

HIV is primarily transmitted through:

### Bodily Fluids

*   **Blood**: Sharing needles or other equipment contaminated with infected blood.
*   **Semen**: Engaging in unprotected sex with an infected person.
*   **Vaginal Fluids**: Engaging in unprotected sex with an infected person.
*   **Breast Milk**: Infected mothers can transmit HIV to their babies through breastfeeding.

### High-Risk Activities

*   **Sharing Needles**: Injecting drugs with shared needles or equipment.
*   **Unprotected Sex**: Engaging in unprotected sex with an infected person.
*   **Mother-to-Child Transmission**: Infected mothers can transmit HIV to their babies during pregnancy, childbirth, or breastfeeding.

### Low-Risk Activities

*   **Kissing**: HIV is not transmitted through kissing, as saliva does not contain enough virus to infect another person.
*   **Sharing Food and Drinks**: HIV is not transmitted through sharing food, drinks, or utensils.
*   **Coughing or Sneezing**: HIV is not transmitted through coughing or sneezing, as the virus is not present in respiratory secretions.
*   **Insect Bites**: HIV is not transmitted through insect bites, as the virus is not present in insect saliva.
*   **Toilet Seats**: HIV is not transmitted through contact with toilet seats or other surfaces contaminated with infected blood or bodily fluids.
*   **Swimming Pools**: HIV is not transmitted through swimming in pools or other bodies of water contaminated with infected blood or bodily fluids.
*   **Air Conditioning**: HIV is not transmitted through air conditioning or other ventilation systems.
*   **Hugging**: HIV is not transmitted through hugging or other casual contact with an infected person.
API call for Meditron failed with error: Connection error.
Starting inference for question locally (Meditron): What comorbidities are common among people living 
<|begin_of_text|><|start_header_id|>system<|end_header_id|>

<|eot_id|><|start_header_id|>user<|end_header_id|>

What comorbidities are common among people living with HIV?<|eot_id|><|start_header_id|>assistant<|end_header_id|>

## Comorbidities Among People Living with HIV

 People living with HIV (PLWH) are at an increased risk of developing various comorbidities due to the compromised immune system and the effects of antiretroviral therapy (ART). Understanding these comorbidities is crucial for providing comprehensive care and improving the quality of life for PLWH.

 ### Common Comorbidities:
 The following comorbidities are commonly observed among people living with HIV:

 ### 1. Cardiovascular Disease
 - Increased risk of heart disease, stroke, and peripheral artery disease
 - Contributing factors include traditional risk factors (e.g., hypertension, diabetes) and HIV-related factors (e.g., inflammation, immune activation)

 ### 2. Diabetes Mellitus
 - Higher prevalence of diabetes among PLWH compared to the general population
 - Contributing factors include insulin resistance, lipodystrophy, and certain antiretroviral medications

 ### 3. Dyslipidemia
 - Abnormal lipid profiles, including high triglycerides and low HDL cholesterol
 - Contributing factors include HIV infection, antiretroviral therapy, and traditional risk factors

 ### 4. Hypertension
 - Increased risk of hypertension among PLWH
 - Contributing factors include traditional risk factors (e.g., obesity, physical inactivity) and HIV-related factors (e.g., inflammation, immune activation)

 ### 5. Chronic Kidney Disease
 - Increased risk of kidney disease among PLWH
 - Contributing factors include traditional risk factors (e.g., hypertension, diabetes) and HIV-related factors (e.g., immune activation, certain antiretroviral medications)

 ### 6. Liver Disease
 - Increased risk of liver disease, including hepatitis and cirrhosis
 - Contributing factors include traditional risk factors (e.g., hepatitis B and C co-infection) and HIV-related factors (e.g., immune activation, certain antiretroviral medications)

 ### 7. Malignancy
 - Increased risk of certain cancers, including Kaposi's sarcoma, non-Hodgkin lymphoma, and lung cancer
 - Contributing factors include traditional risk factors (e.g., smoking) and HIV-related factors (e.g., immune suppression, certain antiretroviral medications)

 ### 8. Osteoporosis
 - Increased risk of osteoporosis among PLWH
 - Contributing factors include traditional risk factors (e.g., low vitamin D levels) and HIV-related factors (e.g., immune activation, certain antiretroviral medications)

 ### 9. Mental Health Disorders
 - Increased risk of mental health disorders, including depression, anxiety, and substance use disorders
 - Contributing factors include traditional risk factors (e.g., social isolation) and HIV-related factors (e.g., stigma, treatment side effects)

 ### 10. Neurocognitive Disorders
 - Increased risk of neurocognitive disorders, including HIV-associated neurocognitive disorder (HAND)
 - Contributing factors include traditional risk factors (e.g., aging) and HIV-related factors (e.g., immune activation, certain antiretroviral medications)

 Understanding these comorbidities is essential for providing comprehensive care and improving the quality of life for people living with HIV.
API call for Meditron failed with error: Connection error.
Starting inference for question locally (Meditron): How can HIV be prevented?
<|begin_of_text|><|start_header_id|>system<|end_header_id|>

<|eot_id|><|start_header_id|>user<|end_header_id|>

How can HIV be prevented?<|eot_id|><|start_header_id|>assistant<|end_header_id|>

## Prevention of HIV

HIV can be prevented through the following measures:

### 1. **Safe Sexual Practices**

- Use condoms correctly and consistently during sexual intercourse.
- Practice monogamy or have sex with only one partner who is HIV-negative and faithful.

### 2. **Blood and Body Fluid Precautions**

- Avoid sharing needles, syringes, or other equipment used for injecting drugs.
- Refrain from sharing personal items like razors, toothbrushes, or nail clippers.

### 3. **Post-Exposure Prophylaxis (PEP)**

- PEP is an emergency medication taken after potential HIV exposure to prevent infection.
- It should be started within 72 hours of exposure.

### 4. **Pre-Exposure Prophylaxis (PrEP)**

- PrEP is a daily medication taken by individuals at high risk of HIV exposure to prevent infection.
- It should be used in conjunction with other prevention methods.

### 5. **Mother-to-Child Transmission Prevention**

- Pregnant women with HIV should receive antiretroviral therapy (ART) to reduce the risk of transmission to their babies.
- ART should be continued during pregnancy, childbirth, and breastfeeding.

### 6. **Testing and Treatment**

- Get tested for HIV regularly to know your status.
- If HIV-positive, start ART immediately to reduce the risk of transmission to others.

### 7. **Avoiding Unprotected Sex**

- Refrain from engaging in unprotected sex with individuals whose HIV status is unknown or positive.
- Use condoms correctly and consistently to reduce the risk of HIV transmission.
API call for Meditron failed with error: Connection error.
Starting inference for question locally (Meditron): How frequently ART must be taken?
<|begin_of_text|><|start_header_id|>system<|end_header_id|>

<|eot_id|><|start_header_id|>user<|end_header_id|>

How frequently ART must be taken?<|eot_id|><|start_header_id|>assistant<|end_header_id|>

## Adherence to Antiretroviral Therapy (ART)

Adherence to ART is crucial for its effectiveness in managing HIV infection. The frequency of taking ART medication depends on the specific regimen prescribed by a healthcare provider.

### Factors Influencing ART Frequency:

- **Regimen Type**: Different ART regimens have varying dosing schedules, ranging from once daily to multiple times a day.
- **Medication Combination**: The combination of medications in an ART regimen can impact the frequency of dosing.
- **Patient Health Status**: Certain health conditions or comorbidities may require adjustments to the ART regimen and dosing schedule.

### Importance of Adherence:

- **Viral Suppression**: Consistent adherence to ART is essential for achieving and maintaining viral suppression, which helps prevent the progression of HIV to AIDS.
- **Resistance Prevention**: Adherence to ART helps prevent the development of drug-resistant HIV strains, which can limit treatment options.

### Conclusion:
The frequency of taking ART medication varies depending on the specific regimen and individual patient needs. It is essential to follow the prescribed dosing schedule and consult with a healthcare provider for guidance on adherence and regimen adjustments.
API call for Meditron failed with error: Connection error.
Starting inference for question locally (Meditron): How can we prevent Perinatal transmission of HIV?
<|begin_of_text|><|start_header_id|>system<|end_header_id|>

<|eot_id|><|start_header_id|>user<|end_header_id|>

How can we prevent Perinatal transmission of HIV?<|eot_id|><|start_header_id|>assistant<|end_header_id|>

## Prevention of Perinatal Transmission of HIV

### Overview

Perinatal transmission of HIV can be prevented through a combination of antiretroviral therapy (ART) and other interventions. The goal is to reduce the viral load in the mother and the risk of transmission to the infant.

### Prevention Strategies

#### 1. Antiretroviral Therapy (ART)

*   **Initiation of ART**: ART should be started as soon as possible in the pregnancy, ideally before 14 weeks of gestation.
*   **Continuation of ART**: ART should be continued throughout the pregnancy, labor, and delivery, and for at least 6 weeks postpartum.

#### 2. Antiretroviral Prophylaxis

*   **Antiretroviral Prophylaxis for the Infant**: The infant should receive antiretroviral prophylaxis for 4-6 weeks after birth.
*   **Antiretroviral Prophylaxis for the Mother**: The mother should receive antiretroviral prophylaxis during labor and delivery.

#### 3. Scheduled Cesarean Delivery

*   **Scheduled Cesarean Delivery**: A scheduled cesarean delivery is recommended for women with a viral load above 1000 copies/mL at 36 weeks of gestation.
*   **Avoiding Labor**: Avoiding labor and delivery can reduce the risk of transmission.

#### 4. Avoiding Breastfeeding

*   **Avoiding Breastfeeding**: Breastfeeding is not recommended for HIV-positive women in the United States.
*   **Alternative Feeding Options**: Alternative feeding options, such as formula feeding, should be used instead.

### Summary

Preventing perinatal transmission of HIV requires a comprehensive approach that includes antiretroviral therapy, antiretroviral prophylaxis, scheduled cesarean delivery, and avoiding breastfeeding. By following these strategies, the risk of transmission can be significantly reduced.
API call for Meditron failed with error: Connection error.
Starting inference for question locally (Meditron): What are the main cell types infected with HIV?
<|begin_of_text|><|start_header_id|>system<|end_header_id|>

<|eot_id|><|start_header_id|>user<|end_header_id|>

What are the main cell types infected with HIV?<|eot_id|><|start_header_id|>assistant<|end_header_id|>

## HIV Infection: Target Cell Types

HIV primarily targets and infects cells of the immune system, leading to the suppression of the body's defense mechanisms. The main cell types infected with HIV are:

### Key Cell Types:
 - **CD4+ T Cells**: Also known as T helper cells, these cells play a crucial role in coordinating the immune response. HIV infects and destroys CD4+ T cells, leading to a weakened immune system.
 - **Macrophages**: These cells are involved in the detection and elimination of pathogens. HIV can infect macrophages, allowing the virus to persist in the body and evade the immune system.

### Summary:
 The primary target cells for HIV infection are CD4+ T cells and macrophages, which are essential components of the immune system. The infection of these cells leads to the progression of HIV to AIDS.
API call for Meditron failed with error: Connection error.
Starting inference for question locally (Meditron): What is the difference between HIV and AIDS?
<|begin_of_text|><|start_header_id|>system<|end_header_id|>

<|eot_id|><|start_header_id|>user<|end_header_id|>

What is the difference between HIV and AIDS?<|eot_id|><|start_header_id|>assistant<|end_header_id|>

## Understanding the Difference Between HIV and AIDS

### What is HIV?

HIV (Human Immunodeficiency Virus) is a virus that attacks the body's immune system, specifically the CD4 cells (T cells), which help the immune system fight off infections. If left untreated, HIV can lead to a weakened immune system.

### What is AIDS?

AIDS (Acquired Immunodeficiency Syndrome) is the final stage of HIV infection, where the virus has severely damaged the immune system, making it difficult for the body to fight off infections and diseases.

### Key Differences:

*   **Immune System Function**: HIV attacks and weakens the immune system, while AIDS is the result of a severely weakened immune system.
*   **Infection Stage**: HIV is the initial stage of infection, while AIDS is the final stage.
*   **Symptoms and Complications**: HIV can cause mild symptoms, while AIDS can lead to severe and life-threatening complications.

### Summary:

HIV is a virus that attacks the immune system, while AIDS is the result of a severely weakened immune system due to HIV infection. Understanding the difference between these two conditions is crucial for effective prevention, diagnosis, and treatment.
API call for Meditron failed with error: Connection error.
Starting inference for question locally (Meditron): How is HIV not transmitted?
<|begin_of_text|><|start_header_id|>system<|end_header_id|>

<|eot_id|><|start_header_id|>user<|end_header_id|>

How is HIV not transmitted?<|eot_id|><|start_header_id|>assistant<|end_header_id|>

HIV is not transmitted through:

1. Casual contact: HIV is not spread through everyday interactions like hugging, kissing, sharing food or drinks, or using the same toilet or shower.

2. Mosquito bites: HIV cannot be transmitted through mosquito bites.

3. Insect bites: HIV cannot be transmitted through insect bites.

4. Air or water: HIV cannot be transmitted through the air or water.

5. Blood transfusions: In developed countries, blood transfusions are screened for HIV and other blood-borne diseases.

6. Saliva, sweat, or tears: HIV cannot be transmitted through saliva, sweat, or tears.

7. Toilet seats: HIV cannot be transmitted through toilet seats.

8. Sharing personal items: HIV cannot be transmitted through sharing personal items like toothbrushes, razors, or towels.

9. Food: HIV cannot be transmitted through food.

10. Swimming pools: HIV cannot be transmitted through swimming pools or hot tubs.
API call for Meditron failed with error: Connection error.
Starting inference for question locally (Meditron): What is known about the switch that occurs between
<|begin_of_text|><|start_header_id|>system<|end_header_id|>

<|eot_id|><|start_header_id|>user<|end_header_id|>

What is known about the switch that occurs between patients with latent HIV and active infection?<|eot_id|><|start_header_id|>assistant<|end_header_id|>

## Switch from Latent HIV to Active Infection

The switch from latent HIV to active infection is a complex process, and there is currently limited understanding of the underlying mechanisms. However, it is believed that the following factors may contribute to this transition:

### Factors Contributing to the Switch

*   **Unknown Factors**: The exact factors that trigger the switch from latent HIV to active infection are not yet fully understood.
*   **Viral Reservoirs**: HIV can remain dormant in various reservoirs, such as immune cells, and can reactivate at any time.
*   **Immune System**: The immune system plays a crucial role in controlling HIV replication, but it can also contribute to the switch to active infection.
*   **Genetic Factors**: Genetic mutations or variations may influence the likelihood of HIV reactivation.
*   **Environmental Factors**: Environmental factors, such as stress or exposure to certain substances, may also contribute to the switch to active infection.

### Current Research and Understanding

While the exact mechanisms of the switch from latent HIV to active infection are not yet fully understood, ongoing research aims to uncover the underlying factors and develop effective strategies for preventing or delaying this transition.
Saved Meditron answers (category=1, iteration=1) to: /cluster/home/gcardenal/HIV/deploy_medical_LLM_evaluation/deploy_medical_llm_evaluation/model_answers/raw/Meditron_cluster/Meditron_answers_category_1.1_HIV_EQ.json
API call for Meditron failed with error: Connection error.
Starting inference for question locally (Meditron): A 58-year-old woman with HIV infection is brought 
<|begin_of_text|><|start_header_id|>system<|end_header_id|>

<|eot_id|><|start_header_id|>user<|end_header_id|>

A 58-year-old woman with HIV infection is brought to the emergency department because of a 2-week history of headaches, blurred vision, and confusion. Her current medications include antiretroviral therapy and trimethoprim-sulfamethoxazole. Neurological examination shows ataxia and memory impairment. Her CD4+ T-lymphocyte count is 90/μL. Analysis of her cerebrospinal fluid analysis shows lymphocytic predominant pleocytosis, and PCR is positive for Epstein-Barr virus DNA. An MRI of the brain with contrast shows a solitary, weakly ring-enhancing lesion with well-defined borders involving the corpus callosum. What is the most likely diagnosis?<|eot_id|><|start_header_id|>assistant<|end_header_id|>

This patient's presentation and imaging findings are suggestive of primary central nervous system lymphoma (PCNSL), a type of non-Hodgkin lymphoma that is more common in immunocompromised individuals, including those with HIV/AIDS. The presence of Epstein-Barr virus DNA in the cerebrospinal fluid is also consistent with this diagnosis, as EBV is often associated with PCNSL in HIV-infected patients. Other possibilities include toxoplasmosis and cryptococcal meningitis, but the MRI findings and the presence of EBV DNA make PCNSL more likely.
API call for Meditron failed with error: Connection error.
Starting inference for question locally (Meditron): A 25-year-old sexually active male presents to an 
<|begin_of_text|><|start_header_id|>system<|end_header_id|>

<|eot_id|><|start_header_id|>user<|end_header_id|>

A 25-year-old sexually active male presents to an internal medicine physician for a routine health check up after having several unprotected sexual encounters. After appropriate testing the physician discusses with the patient that he is HIV+ and must be started on anti-retroviral treatment. What medication prescribed acts on the gp41 subunit of the HIV envelope glycoprotein?<|eot_id|><|start_header_id|>assistant<|end_header_id|>

The medication that acts on the gp41 subunit of the HIV envelope glycoprotein is Enfuvirtide (T-20). It is a fusion inhibitor that prevents the entry of HIV into the host cells by blocking the fusion of the viral envelope with the host cell membrane. Enfuvirtide is administered via subcutaneous injection and is typically used in combination with other antiretroviral medications for the treatment of HIV infection.
API call for Meditron failed with error: Connection error.
Starting inference for question locally (Meditron): A mother with HIV has given birth to a healthy boy
<|begin_of_text|><|start_header_id|>system<|end_header_id|>

<|eot_id|><|start_header_id|>user<|end_header_id|>

A mother with HIV has given birth to a healthy boy 2 days ago. She takes her antiretroviral medication regularly and is compliant with the therapy. Before being discharged, her doctor explains that she cannot breastfeed the child since there is a risk of infection through breastfeeding and stresses that the child can benefit from formula feeding. The physician stresses the importance of not overheating the formula since Vitamin C may be inactivated by overheating. What molecular process could be impaired if the mother boiled the formula longer than needed?<|eot_id|><|start_header_id|>assistant<|end_header_id|>

The molecular process that could be impaired if the mother boiled the formula longer than needed is the oxidation-reduction reaction that involves Vitamin C. Vitamin C is a water-soluble vitamin that acts as an antioxidant and is important for the synthesis of collagen, absorption of iron, and immune function. When Vitamin C is exposed to high temperatures, it can be oxidized and inactivated, which can lead to a deficiency of this essential nutrient in the child. Therefore, it is important for the mother to follow the instructions for preparing the formula to ensure that the Vitamin C is not destroyed by overheating.
API call for Meditron failed with error: Connection error.
Starting inference for question locally (Meditron): A 35-year-old woman presents to a physician’s offi
<|begin_of_text|><|start_header_id|>system<|end_header_id|>

<|eot_id|><|start_header_id|>user<|end_header_id|>

A 35-year-old woman presents to a physician’s office for a follow-up visit. She recently underwent a complete physical examination with routine laboratory tests. She also had a Pap smear and testing for sexually transmitted diseases. Since her divorce 2 years ago, she had sexual encounters with random men at bars or social events and frequently did not use any form of protection during sexual intercourse. She was shown to be positive for the human immunodeficiency virus (HIV). Combination anti-retroviral treatment is initiated including zidovudine, didanosine, and efavirenz. One week later, she is rushed to the hospital where she is diagnosed with acute pancreatitis. What precautions in her medication will be required after pancreatitis resolves with treatment?<|eot_id|><|start_header_id|>assistant<|end_header_id|>

The patient's acute pancreatitis is likely a result of didanosine, a nucleoside reverse transcriptase inhibitor (NRTI) used in the treatment of HIV. Didanosine is known to cause pancreatitis as a side effect. Once the pancreatitis resolves, the patient's medication regimen should be modified to avoid didanosine and prevent a recurrence of pancreatitis. The patient's treatment regimen can be modified to include other NRTIs such as tenofovir, abacavir, or lamivudine, which do not have a significant risk of causing pancreatitis. The patient should also be educated on the importance of adherence to her medication regimen and regular follow-up with her healthcare provider to monitor her response to treatment and prevent any potential complications.
API call for Meditron failed with error: Connection error.
Starting inference for question locally (Meditron): A physician scientist is looking for a more effici
<|begin_of_text|><|start_header_id|>system<|end_header_id|>

<|eot_id|><|start_header_id|>user<|end_header_id|>

A physician scientist is looking for a more efficient way to treat HIV. Patients infected with HIV mount a humoral immune response by producing antibodies against the HIV envelope proteins. These antibodies are the same antibodies detected by the ELISA and western blot assays used to diagnose the disease. The physician scientist is trying to generate a new, more potent antibody against the same HIV envelope proteins targeted by the natural humoral immune response. Of the following proteins, which is the most likely target of the antibody he is designing?<|eot_id|><|start_header_id|>assistant<|end_header_id|>

### Understanding the Humoral Immune Response to HIV

The humoral immune response is a crucial component of the body's defense against pathogens, including viruses like HIV. When a person is infected with HIV, their immune system produces antibodies to fight the virus. These antibodies are directed against specific proteins on the surface of the virus, known as envelope proteins.

### Identifying the Target of the Antibody

To design a more potent antibody against HIV, the physician scientist needs to identify the specific envelope protein that is targeted by the natural humoral immune response. The main envelope protein of HIV is:

### gp120: The Primary Target of the Humoral Immune Response

*   **Glycoprotein 120 (gp120)**: This is the primary envelope protein of HIV that is recognized by the immune system.
*   **Role in Viral Entry**: gp120 plays a critical role in the entry of HIV into host cells by binding to the CD4 receptor and co-receptors on the surface of immune cells.
*   **Antibody Target**: As a result, gp120 is the most likely target of the antibody being designed by the physician scientist.

### Conclusion

Based on the understanding of the humoral immune response to HIV and the role of gp120 in viral entry, the most likely target of the antibody being designed is **gp120**.
API call for Meditron failed with error: Connection error.
Starting inference for question locally (Meditron): A 50-year-old HIV-positive male presents to the ER
<|begin_of_text|><|start_header_id|>system<|end_header_id|>

<|eot_id|><|start_header_id|>user<|end_header_id|>

A 50-year-old HIV-positive male presents to the ER with a two-day history of fever and hemoptysis. Chest radiograph shows a fibrocavitary lesion in the right middle lobe. Biopsy of the afflicted area demonstrates septate hyphae that branch at acute angles. What is the most likely causal organism?<|eot_id|><|start_header_id|>assistant<|end_header_id|>

The patient's presentation, along with the biopsy findings of septate hyphae branching at acute angles, is suggestive of an invasive aspergillosis infection, most likely caused by Aspergillus fumigatus. Aspergillus is a common opportunistic pathogen in immunocompromised patients, including those with HIV/AIDS. Treatment typically involves antifungal therapy with voriconazole, and the patient may also benefit from immune reconstitution with antiretroviral therapy.
API call for Meditron failed with error: Connection error.
Starting inference for question locally (Meditron): A 43-year-old man with HIV infection comes to the 
<|begin_of_text|><|start_header_id|>system<|end_header_id|>

<|eot_id|><|start_header_id|>user<|end_header_id|>

A 43-year-old man with HIV infection comes to the physician because of a 2-week history of progressive diarrhea and a 3-kg (6.6-lb) weight loss. During this period, he has had 3–4 episodes of watery stools daily, with multiple instances of blood in the stool. He is currently receiving antiretroviral therapy with zidovudine, lamivudine, and dolutegravir. Physical examination shows pallor and dry mucous membranes. A colonoscopy shows multiple linear ulcers. Polymerase chain reaction of a stool sample is positive for cytomegalovirus. Treatment with valganciclovir is begun. Adding this drug to his current medication regimen puts this patient at greatest risk for what specific adverse effects?<|eot_id|><|start_header_id|>assistant<|end_header_id|>

This patient is at risk for bone marrow suppression, specifically anemia and neutropenia, due to the combination of zidovudine and valganciclovir. Both drugs can cause bone marrow suppression, and their concurrent use increases the risk of these adverse effects.
API call for Meditron failed with error: Connection error.
Starting inference for question locally (Meditron): A 28-year-old G1P0 woman at 16 weeks estimated ges
<|begin_of_text|><|start_header_id|>system<|end_header_id|>

<|eot_id|><|start_header_id|>user<|end_header_id|>

A 28-year-old G1P0 woman at 16 weeks estimated gestational age presents for prenatal care. Routine prenatal screening tests are performed and reveal a positive HIV antibody test. The patient is extremely concerned about the possible transmission of HIV to her baby and wants to have the baby tested as soon as possible after delivery. Which of the following would be the most appropriate diagnostic test to address this patient’s concern?<|eot_id|><|start_header_id|>assistant<|end_header_id|>

The most appropriate diagnostic test for a newborn whose mother is HIV-positive would be the HIV DNA PCR test. This test detects the presence of HIV DNA in the baby's blood and is typically performed within the first 48 hours after birth. The HIV antibody test is not appropriate for newborns because the mother's antibodies can cross the placenta and remain in the baby's blood for up to 18 months, even if the baby is not infected. Therefore, a positive antibody test in a newborn does not necessarily mean that the baby is infected with HIV. The HIV DNA PCR test is more accurate and can provide a definitive diagnosis of HIV infection in newborns.
API call for Meditron failed with error: Connection error.
Starting inference for question locally (Meditron): A 32-year-old man comes to the office for a routin
<|begin_of_text|><|start_header_id|>system<|end_header_id|>

<|eot_id|><|start_header_id|>user<|end_header_id|>

A 32-year-old man comes to the office for a routine health maintenance examination. He admits to recently having an affair several months ago and requests STD testing. One week later, the results of a fourth-generation HIV antibody and antigen test return positive. The patient is counseled on the test result. The patient requests that his diagnosis not be disclosed to anyone, including his wife. The man's wife is also the physician's patient. What should be the most appropriate next step by the physician?<|eot_id|><|start_header_id|>assistant<|end_header_id|>

The physician should encourage the patient to disclose his diagnosis to his wife. If the patient refuses, the physician should inform the patient that the physician has a legal obligation to protect the wife from harm and may be required to notify her of the potential risk of HIV transmission. However, the physician should also inform the patient that the physician will try to persuade the patient to disclose his diagnosis to his wife before taking any action. The physician should also offer to assist the patient in disclosing his diagnosis to his wife. If the patient still refuses to disclose his diagnosis to his wife, the physician may be required to notify the wife of the potential risk of HIV transmission. The physician should document all discussions with the patient and any actions taken to protect the wife.
API call for Meditron failed with error: Connection error.
Starting inference for question locally (Meditron): A 41-year-old HIV-positive male presents to the ER
<|begin_of_text|><|start_header_id|>system<|end_header_id|>

<|eot_id|><|start_header_id|>user<|end_header_id|>

A 41-year-old HIV-positive male presents to the ER with a 4-day history of headaches and nuchal rigidity. A lumbar puncture shows an increase in CSF protein and a decrease in CSF glucose. When stained with India ink, light microscopy of the patient’s CSF reveals encapsulated yeast with narrow-based buds. Assuming a single pathogenic organism is responsible for this patient’s symptoms, what diagnostic test results would also be expected in this patient?<|eot_id|><|start_header_id|>assistant<|end_header_id|>

The patient's presentation is suggestive of cryptococcal meningitis, a common opportunistic infection in HIV-positive individuals. The diagnostic test results that would also be expected in this patient include a positive cryptococcal antigen test and a positive culture for Cryptococcus neoformans.
API call for Meditron failed with error: Connection error.
Starting inference for question locally (Meditron):  What would be the best methodological approach to
<|begin_of_text|><|start_header_id|>system<|end_header_id|>

<|eot_id|><|start_header_id|>user<|end_header_id|>

What would be the best methodological approach to study microRNAs as therapeutic targets in HIV patients?<|eot_id|><|start_header_id|>assistant<|end_header_id|>

The best methodological approach to study microRNAs as therapeutic targets in HIV patients would involve a combination of in vitro and in vivo studies. In vitro studies could involve the use of cell culture models to investigate the role of specific microRNAs in HIV replication and pathogenesis. This could involve the use of microRNA mimics and inhibitors to modulate microRNA expression and assess their impact on HIV replication and cellular responses. In vivo studies could involve the use of animal models of HIV infection to investigate the therapeutic potential of microRNA-based therapies. This could involve the use of microRNA mimics or inhibitors delivered via viral vectors or nanoparticles to target specific tissues and cells in the body. Additionally, clinical trials in HIV patients could be conducted to evaluate the safety and efficacy of microRNA-based therapies. These trials could involve the use of microRNA mimics or inhibitors delivered via intravenous or subcutaneous injection, and could involve the monitoring of viral load, immune function, and other clinical outcomes. Overall, a combination of in vitro and in vivo studies, as well as clinical trials, would be necessary to fully evaluate the potential of microRNAs as therapeutic targets in HIV patients.
API call for Meditron failed with error: Connection error.
Starting inference for question locally (Meditron): What is known about DNA methylation profiles in pa
<|begin_of_text|><|start_header_id|>system<|end_header_id|>

<|eot_id|><|start_header_id|>user<|end_header_id|>

What is known about DNA methylation profiles in patients with latent HIV-1 or with an active infection?<|eot_id|><|start_header_id|>assistant<|end_header_id|>

## DNA Methylation Profiles in HIV-1 Infection

 DNA methylation is a crucial epigenetic mechanism that regulates gene expression. In the context of HIV-1 infection, DNA methylation profiles have been studied to understand the disease progression and the mechanisms underlying HIV-1 latency.

 ### Understanding HIV-1 Latency:
 HIV-1 latency is a state where the virus remains dormant within infected cells, making it difficult to detect and treat. This latency is characterized by the presence of integrated proviral DNA, which is not actively transcribed.

 ### DNA Methylation and HIV-1 Latency:
 Research has shown that DNA methylation plays a significant role in regulating HIV-1 latency. Specifically, DNA methylation of the HIV-1 long terminal repeat (LTR) region has been observed in patients with latent HIV-1 infection.

 ### Key Findings:
 - **DNA Methylation of HIV-1 LTR**:
 - DNA methylation of the HIV-1 LTR region is present in patients with latent HIV-1 infection.
 - This methylation is thought to contribute to the maintenance of HIV-1 latency by silencing viral gene expression.

 ### Implications:
 Understanding the role of DNA methylation in HIV-1 latency has significant implications for the development of novel therapeutic strategies aimed at reactivating latent HIV-1 and eliminating the virus from infected cells.
Saved Meditron answers (category=3, iteration=1) to: /cluster/home/gcardenal/HIV/deploy_medical_LLM_evaluation/deploy_medical_llm_evaluation/model_answers/raw/Meditron_cluster/Meditron_answers_category_3.1_HIV_EQ.json
API call for Meditron failed with error: Connection error.
Starting inference for question locally (Meditron): A 26-year-old female with AIDS (CD4 count: 47) pre
<|begin_of_text|><|start_header_id|>system<|end_header_id|>

<|eot_id|><|start_header_id|>user<|end_header_id|>

A 26-year-old female with AIDS (CD4 count: 47) presents to the emergency department in severe pain. She states that over the past week she has been fatigued and has had a progressively worse headache and fever. These symptoms have failed to remit leading her to seek care in the ED. A lumbar puncture is performed which demonstrates an opening pressure of 285 mm H2O, increased lymphocytes, elevated protein, and decreased glucose. The emergency physician subsequently initiates treatment with IV amphotericin B and PO flucytosine. What additional treatment in the acute setting may be warranted in this patient?<|eot_id|><|start_header_id|>assistant<|end_header_id|>

This patient's presentation is suggestive of cryptococcal meningitis, a common opportunistic infection in patients with advanced HIV/AIDS. The treatment with IV amphotericin B and PO flucytosine is appropriate. However, the elevated opening pressure on lumbar puncture suggests increased intracranial pressure, which can be life-threatening. In this case, repeated lumbar punctures to reduce intracranial pressure may be warranted, along with careful monitoring of the patient's neurological status.
API call for Meditron failed with error: Connection error.
Starting inference for question locally (Meditron): You are reviewing raw data from a research study p
<|begin_of_text|><|start_header_id|>system<|end_header_id|>

<|eot_id|><|start_header_id|>user<|end_header_id|>

You are reviewing raw data from a research study performed at your medical center examining the effectiveness of a novel AIDS screening examination. The study enrolled 250 patients with confirmed AIDS, and 240 of these patients demonstrated a positive screening examination. The control arm of the study enrolled 250 patients who do not have AIDS, and only 5 of these patients tested positive on the novel screening examination. What is the NPV of this novel test?<|eot_id|><|start_header_id|>assistant<|end_header_id|>

## Calculating the Negative Predictive Value (NPV) of a Novel AIDS Screening Test

### Background:
To determine the Negative Predictive Value (NPV) of a novel AIDS screening test, we need to understand the following concepts:

* **True Negatives (TN)**: Patients who do not have AIDS and test negative on the screening examination.
* **False Negatives (FN)**: Patients who have AIDS but test negative on the screening examination.

### Study Data:
- **AIDS Patients (n=250)**:
  - Positive Screening Results: 240
  - Negative Screening Results: 10 (False Negatives)
- **Control Arm (n=250)**:
  - Positive Screening Results: 5
  - Negative Screening Results: 245 (True Negatives)

### Calculating NPV:
The Negative Predictive Value (NPV) is calculated as follows:

NPV = TN / (TN + FN)

### Substituting Values:
- TN = 245 (True Negatives in the control arm)
- FN = 10 (False Negatives in the AIDS patient group)

NPV = 245 / (245 + 10)
NPV = 245 / 255
NPV = 0.96

### Conclusion:
The Negative Predictive Value (NPV) of the novel AIDS screening test is 0.96, indicating that 96% of patients who test negative on the screening examination do not have AIDS.
API call for Meditron failed with error: Connection error.
Starting inference for question locally (Meditron): A 46-year-old Caucasian male with past medical his
<|begin_of_text|><|start_header_id|>system<|end_header_id|>

<|eot_id|><|start_header_id|>user<|end_header_id|>

A 46-year-old Caucasian male with past medical history of HIV (CD4: 77/mm^3), hypertension, hyperlipidemia, and osteoarthritis presents to the emergency department with sudden weakness of his right hand. He reports that the weakness has gradually been getting worse and that this morning he dropped his cup of coffee. He has never had anything like this happen to him before, although he was hospitalized last year for pneumonia. He reports inconsistent adherence to his home medications, which include raltegravir, tenofovir, emtricitabine, TMP-SMX, hydrochlorothiazide, pravastatin, and occasional ibuprofen. His father died of a myocardial infarction at the age of 60, and his mother suffered a stroke at the age of 72. The patient's temperature is 102.6°F (39.2°C), blood pressure is 156/92 mmHg, pulse is 88/min, and respirations are 18/min. On neurological exam, he has 3/5 strength in the distal muscles of the right extremity with preserved sensation. His neurological exam is normal in all other extremities. What is the next best step in management for this patient?<|eot_id|><|start_header_id|>assistant<|end_header_id|>

The patient's presentation of sudden weakness in one extremity, fever, and history of HIV infection raises concern for an opportunistic infection such as cryptococcal meningitis or toxoplasmosis. Given his fever and neurological symptoms, he should be admitted to the hospital for further evaluation and management. The next best step would be to obtain a lumbar puncture to evaluate for possible central nervous system infection. Additionally, the patient's HIV regimen should be reviewed and optimized, and he should be started on appropriate antibiotics to cover for potential bacterial infections.
API call for Meditron failed with error: Connection error.
Starting inference for question locally (Meditron): A 44-year-old man is brought to the emergency depa
<|begin_of_text|><|start_header_id|>system<|end_header_id|>

<|eot_id|><|start_header_id|>user<|end_header_id|>

A 44-year-old man is brought to the emergency department by his daughter for a 1-week history of right leg weakness, unsteady gait, and multiple falls. During the past 6 months, he has become more forgetful and has sometimes lost his way along familiar routes. He has been having difficulties operating simple kitchen appliances such as the dishwasher and the coffee maker. He has recently become increasingly paranoid, agitated, and restless. He has HIV, hypertension, and type 2 diabetes mellitus. His last visit to a physician was more than 2 years ago, and he has been noncompliant with his medications. His temperature is 37.2 °C (99.0 °F), blood pressure is 152/68 mm Hg, pulse is 98/min, and respirations are 14/min. He is somnolent and slightly confused. He is oriented to person, but not place or time. There is mild lymphadenopathy in the cervical, axillary, and inguinal areas. Neurological examination shows right lower extremity weakness with normal tone and no other focal deficits. Laboratory studies show: Hemoglobin 9.2 g/dL, Leukocyte count 3600/mm3, Platelet count 140,000/mm3, CD4+ count 56/μL, HIV viral load > 100,000 copies/mL, Serum: Cryptococcal antigen negative, Toxoplasma gondii IgG positive. An MRI of the brain shows disseminated, nonenhancing white matter lesions with no mass effect. What is the most likely diagnosis?<|eot_id|><|start_header_id|>assistant<|end_header_id|>

This patient's clinical presentation, including cognitive decline, personality changes, and motor deficits, in the context of advanced HIV disease with a low CD4+ count, is suggestive of HIV-associated neurocognitive disorder (HAND). The MRI findings of disseminated, nonenhancing white matter lesions without mass effect further support this diagnosis. HAND is a common complication of HIV infection, particularly in individuals with advanced immunosuppression. The patient's positive Toxoplasma gondii IgG suggests prior exposure, but this is not indicative of active toxoplasmosis, which typically presents with focal neurological deficits and enhancing lesions on MRI. Cryptococcal antigen is negative, ruling out cryptococcal meningitis. Other differentials such as progressive multifocal leukoencephalopathy (PML) and primary CNS lymphoma are less likely given the MRI findings and the absence of specific diagnostic markers.
API call for Meditron failed with error: Connection error.
Starting inference for question locally (Meditron): A 25-year-old nulliparous woman at 8 weeks' gestat
<|begin_of_text|><|start_header_id|>system<|end_header_id|>

<|eot_id|><|start_header_id|>user<|end_header_id|>

A 25-year-old nulliparous woman at 8 weeks' gestation comes to her physician accompanied by her husband for her first prenatal visit. She has no personal or family history of serious illness. Her vaccinations are up-to-date and she takes no medications. She has no history of recreational drug use and does not drink alcohol. Her vital signs are within normal limits. She is 167 cm (5 ft 6 in) tall and weighs 68 kg (150 lb); BMI is 24.3 kg/m2. She tested negative for HIV, Chlamydia trachomatis, and Neisseria gonorrhoeae 4 years ago. What following tests should be done at this visit?<|eot_id|><|start_header_id|>assistant<|end_header_id|>

The following tests should be done at this visit: 

1. Blood type and antibody screen: To check for any antibodies against Rh factor and other blood group antigens.

2. Complete blood count (CBC): To assess for anemia and other hematological abnormalities.

3. Urinalysis: To check for protein, glucose, and ketones, which can indicate gestational diabetes or preeclampsia.

4. Rubella antibody screen: To determine if the patient is immune to rubella, which can cause congenital rubella syndrome in the fetus if contracted during pregnancy.

5. Syphilis screen: To check for syphilis, which can cause serious complications in the fetus if left untreated.

6. Hepatitis B surface antigen: To check for hepatitis B infection, which can be transmitted to the fetus during delivery.

7. Pap smear: To screen for cervical cancer and pre-cancerous changes.

8. Gonorrhea and Chlamydia testing: If the patient is at high risk for sexually transmitted infections, such as having multiple sexual partners or a history of STIs.

9. HIV testing: If the patient is at high risk for HIV, such as having multiple sexual partners or a history of IV drug use.
API call for Meditron failed with error: Connection error.
Starting inference for question locally (Meditron): A 33-year-old HIV-positive male is seen in clinic 
<|begin_of_text|><|start_header_id|>system<|end_header_id|>

<|eot_id|><|start_header_id|>user<|end_header_id|>

A 33-year-old HIV-positive male is seen in clinic for follow-up care. When asked if he has been adhering to his HIV medications, the patient exclaims that he has been depressed, thus causing him to not take his medication for six months. His CD4+ count is now 33 cells/mm3. What medication(s) should he take in addition to his anti-retroviral therapy?<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Given the patient's low CD4+ count, he is at risk for opportunistic infections. In addition to his anti-retroviral therapy, he should be started on prophylaxis for Pneumocystis jirovecii pneumonia (PCP), such as trimethoprim-sulfamethoxazole (TMP-SMX). His depression should also be addressed with appropriate treatment.
API call for Meditron failed with error: Connection error.
Starting inference for question locally (Meditron): A 30-year-old woman with HIV comes to the emergenc
<|begin_of_text|><|start_header_id|>system<|end_header_id|>

<|eot_id|><|start_header_id|>user<|end_header_id|>

A 30-year-old woman with HIV comes to the emergency department because of fever and multiple skin lesions for 1 week. She also has nausea, anorexia, and abdominal pain. The skin lesions are non-pruritic and painless. She has smoked one pack of cigarettes daily for 15 years and drinks 2 beers daily. She has been using intravenous crack cocaine for 6 years. She appears ill. Her temperature is 38°C (100.4°F), pulse is 105/min, blood pressure is 110/75 mm Hg. Her BMI is 19 kg/m2. Examination shows track marks on both cubital fossae. There are white patches on her palate that can be scraped off. There are several red papules measuring 1 to 2 cm on her face and trunk. Her CD4+T-lymphocyte count is 98/mm3 (N ≥ 500). Biopsy of a skin lesion shows vascular proliferation and small black bacteria on Warthin-Starry stain. What is the most appropriate pharmacotherapy?<|eot_id|><|start_header_id|>assistant<|end_header_id|>

The patient's presentation is suggestive of Bacillary angiomatosis, a condition associated with Bartonella henselae infection. The diagnosis is supported by the presence of vascular proliferation and small black bacteria on Warthin-Starry stain. The appropriate treatment for Bacillary angiomatosis is erythromycin, which is effective against Bartonella henselae.
API call for Meditron failed with error: Connection error.
Starting inference for question locally (Meditron): A 35-year-old man comes to the physician because o
<|begin_of_text|><|start_header_id|>system<|end_header_id|>

<|eot_id|><|start_header_id|>user<|end_header_id|>

A 35-year-old man comes to the physician because of a 6-month history of fatigue and increased sweating at night. He says that he feels 'constantly tired' and needs more rest than usual although he sleeps well. In the morning, his sheets are often wet and his skin is clammy. He has not had any sore throat, runny nose, or cough recently. He has not traveled anywhere. Over the past 4 months, he has had a 6.8-kg (15-lb) weight loss, despite having a normal appetite. He does not drink or urinate more than usual. He is 181 cm (5 ft 11 in) tall and weighs 72 kg (159 lb); BMI is 22 kg/m2. His temperature is 37.9°C (100.2°F), pulse is 65/min, and blood pressure is 120/70 mm Hg. Physical examination shows no abnormalities. An HIV screening test and confirmatory test are both positive. The CD4 count is 600 cells/μl and the viral load is 104 copies/mL. Treatment with lamivudine, zidovudine, and indinavir is begun. The patient is at greatest risk for what adverse effects?<|eot_id|><|start_header_id|>assistant<|end_header_id|>

The patient is at greatest risk for developing lactic acidosis, which is a known adverse effect of nucleoside reverse transcriptase inhibitors (NRTIs) such as lamivudine and zidovudine. Lactic acidosis is a rare but serious complication that can occur with long-term use of NRTIs. Symptoms include fatigue, nausea, vomiting, abdominal pain, and shortness of breath. The patient's symptoms of fatigue and weight loss may be related to the HIV infection itself, but the development of lactic acidosis should be monitored closely during treatment with NRTIs.
API call for Meditron failed with error: Connection error.
Starting inference for question locally (Meditron): A 52-year-old man is brought to the emergency depa
<|begin_of_text|><|start_header_id|>system<|end_header_id|>

<|eot_id|><|start_header_id|>user<|end_header_id|>

A 52-year-old man is brought to the emergency department because of headaches, vertigo, and changes to his personality for the past few weeks. He was diagnosed with HIV 14 years ago and was started on antiretroviral therapy at that time. Medical records from one month ago indicate that he followed his medication schedule inconsistently. Since then, he has been regularly taking his antiretroviral medications and trimethoprim-sulfamethoxazole. His vital signs are within normal limits. Neurological examination shows ataxia and apathy. Mini-Mental State Examination score is 15/30. Laboratory studies show: Hemoglobin 12.5 g/dL Leukocyte count 8400/mm3 Segmented neutrophils 80% Eosinophils 1% Lymphocytes 17% Monocytes 2% CD4+ T-lymphocytes 90/μL Platelet count 328,000/mm3 An MRI of the brain with contrast shows a solitary ring-enhancing lesion involving the corpus callosum and measuring 4.5 cm in diameter. A lumbar puncture with subsequent cerebrospinal fluid analysis shows slight pleocytosis, and PCR is positive for Epstein-Barr virus DNA. What is the most likely diagnosis?<|eot_id|><|start_header_id|>assistant<|end_header_id|>

The patient's symptoms and laboratory findings suggest that he has primary central nervous system lymphoma (PCNSL), which is a type of non-Hodgkin lymphoma that arises within the brain or spinal cord. The presence of a solitary ring-enhancing lesion on MRI and the positive PCR for Epstein-Barr virus DNA in the cerebrospinal fluid are key diagnostic clues. PCNSL is a common complication of advanced HIV infection, particularly in patients with low CD4+ T-lymphocyte counts, and is often associated with Epstein-Barr virus infection. The patient's history of inconsistent adherence to antiretroviral therapy and low CD4+ T-lymphocyte count further support this diagnosis.
API call for Meditron failed with error: Connection error.
Starting inference for question locally (Meditron): A 2300-g (5-lb 1-oz) male newborn is delivered to 
<|begin_of_text|><|start_header_id|>system<|end_header_id|>

<|eot_id|><|start_header_id|>user<|end_header_id|>

A 2300-g (5-lb 1-oz) male newborn is delivered to a 29-year-old primigravid woman. The mother has HIV and received triple antiretroviral therapy during pregnancy. Her HIV viral load was 678 copies/mL 1 week prior to delivery. Labor was uncomplicated. Apgar scores are 7 and 8 at 1 and 5 minutes respectively. Physical examination of the newborn shows no abnormalities. What is the most appropriate next step in management of this infant?<|eot_id|><|start_header_id|>assistant<|end_header_id|>

The infant should be started on antiretroviral prophylaxis as soon as possible, ideally within 6-12 hours of birth. The specific regimen depends on the mother's viral load at delivery. If the viral load is less than 1000 copies/mL, the infant should receive zidovudine for 4 weeks. If the viral load is greater than 1000 copies/mL, the infant should receive zidovudine and nevirapine for 2 weeks. The infant should also receive routine newborn care, including vaccinations and follow-up appointments. The mother should continue her antiretroviral therapy and be monitored for any signs of HIV-related complications.
Saved Meditron answers (category=4, iteration=1) to: /cluster/home/gcardenal/HIV/deploy_medical_LLM_evaluation/deploy_medical_llm_evaluation/model_answers/raw/Meditron_cluster/Meditron_answers_category_4.1_HIV_EQ.json
Loading Med42 model...
Loading checkpoint shards:   0%|                                                     | 0/30 [00:00<?, ?it/s]Loading checkpoint shards:   3%|█▌                                           | 1/30 [00:12<06:06, 12.64s/it]Loading checkpoint shards:   7%|███                                          | 2/30 [00:16<03:26,  7.36s/it]Loading checkpoint shards:  10%|████▌                                        | 3/30 [00:30<04:48, 10.70s/it]Loading checkpoint shards:  13%|██████                                       | 4/30 [00:34<03:25,  7.91s/it]Loading checkpoint shards:  17%|███████▌                                     | 5/30 [01:35<11:15, 27.01s/it]Loading checkpoint shards:  20%|█████████                                    | 6/30 [02:12<12:07, 30.33s/it]Loading checkpoint shards:  23%|██████████▌                                  | 7/30 [02:16<08:22, 21.86s/it]Loading checkpoint shards:  27%|████████████                                 | 8/30 [02:23<06:15, 17.08s/it]Loading checkpoint shards:  30%|█████████████▌                               | 9/30 [02:28<04:39, 13.30s/it]Loading checkpoint shards:  33%|██████████████▋                             | 10/30 [03:28<09:12, 27.64s/it]Loading checkpoint shards:  37%|████████████████▏                           | 11/30 [03:33<06:35, 20.83s/it]Loading checkpoint shards:  40%|█████████████████▌                          | 12/30 [03:38<04:45, 15.88s/it]Loading checkpoint shards:  43%|███████████████████                         | 13/30 [03:50<04:11, 14.77s/it]Loading checkpoint shards:  47%|████████████████████▌                       | 14/30 [04:02<03:44, 14.03s/it]Loading checkpoint shards:  50%|██████████████████████                      | 15/30 [04:13<03:13, 12.90s/it]Loading checkpoint shards:  53%|███████████████████████▍                    | 16/30 [04:17<02:24, 10.30s/it]Loading checkpoint shards:  57%|████████████████████████▉                   | 17/30 [05:01<04:27, 20.58s/it]Loading checkpoint shards:  60%|██████████████████████████▍                 | 18/30 [05:05<03:07, 15.64s/it]Loading checkpoint shards:  63%|███████████████████████████▊                | 19/30 [05:14<02:29, 13.58s/it]Loading checkpoint shards:  67%|█████████████████████████████▎              | 20/30 [06:32<05:28, 32.83s/it]Loading checkpoint shards:  70%|██████████████████████████████▊             | 21/30 [06:44<03:58, 26.54s/it]Loading checkpoint shards:  73%|████████████████████████████████▎           | 22/30 [06:49<02:41, 20.14s/it]Loading checkpoint shards:  77%|█████████████████████████████████▋          | 23/30 [06:52<01:44, 14.91s/it]Loading checkpoint shards:  80%|███████████████████████████████████▏        | 24/30 [06:53<01:05, 10.92s/it]Loading checkpoint shards:  83%|████████████████████████████████████▋       | 25/30 [06:54<00:39,  7.99s/it]Loading checkpoint shards:  87%|██████████████████████████████████████▏     | 26/30 [06:55<00:23,  5.76s/it]Loading checkpoint shards:  90%|███████████████████████████████████████▌    | 27/30 [06:56<00:12,  4.27s/it]Loading checkpoint shards:  93%|█████████████████████████████████████████   | 28/30 [06:56<00:06,  3.06s/it]Loading checkpoint shards:  97%|██████████████████████████████████████████▌ | 29/30 [07:00<00:03,  3.18s/it]Loading checkpoint shards: 100%|████████████████████████████████████████████| 30/30 [07:00<00:00,  2.29s/it]Loading checkpoint shards: 100%|████████████████████████████████████████████| 30/30 [07:00<00:00, 14.01s/it]
Some parameters are on the meta device because they were offloaded to the cpu.
Starting inference for question (Med42): How is HIV diagnosed?
slurmstepd: error: *** STEP 21166741.0 ON eu-a65-06 CANCELLED AT 2025-01-18T14:53:13 ***
slurmstepd: error: *** JOB 21166741 ON eu-a65-06 CANCELLED AT 2025-01-18T14:53:13 ***
W0118 14:53:13.529000 23125024229184 torch/distributed/elastic/agent/server/api.py:741] Received 15 death signal, shutting down workers
W0118 14:53:13.529000 23125024229184 torch/distributed/elastic/multiprocessing/api.py:851] Sending process 3608031 closing signal SIGTERM
